| Product Code: ETC5360165 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Gastrointestinal Diseases Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Gastrointestinal Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Gastrointestinal Diseases Market - Industry Life Cycle |
3.4 Austria Gastrointestinal Diseases Market - Porter's Five Forces |
3.5 Austria Gastrointestinal Diseases Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Austria Gastrointestinal Diseases Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Austria Gastrointestinal Diseases Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Austria Gastrointestinal Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal diseases in Austria |
4.2.2 Growing awareness about gastrointestinal health and related disorders |
4.2.3 Technological advancements in diagnostic and treatment options for gastrointestinal diseases |
4.3 Market Restraints |
4.3.1 High treatment costs associated with gastrointestinal diseases |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Austria |
4.3.3 Stringent regulatory policies impacting the introduction of new therapies in the market |
5 Austria Gastrointestinal Diseases Market Trends |
6 Austria Gastrointestinal Diseases Market Segmentations |
6.1 Austria Gastrointestinal Diseases Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Austria Gastrointestinal Diseases Market Revenues & Volume, By Antacids, 2021-2031F |
6.1.3 Austria Gastrointestinal Diseases Market Revenues & Volume, By Laxatives, 2021-2031F |
6.1.4 Austria Gastrointestinal Diseases Market Revenues & Volume, By Antidiarrheal Agents, 2021-2031F |
6.1.5 Austria Gastrointestinal Diseases Market Revenues & Volume, By Antiemetics, 2021-2031F |
6.1.6 Austria Gastrointestinal Diseases Market Revenues & Volume, By Antiulcer Agents, 2021-2031F |
6.1.7 Austria Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
6.2 Austria Gastrointestinal Diseases Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Austria Gastrointestinal Diseases Market Revenues & Volume, By Oral, 2021-2031F |
6.2.3 Austria Gastrointestinal Diseases Market Revenues & Volume, By Parenteral, 2021-2031F |
6.2.4 Austria Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
6.3 Austria Gastrointestinal Diseases Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Austria Gastrointestinal Diseases Market Revenues & Volume, By Ulcerative Colitis, 2021-2031F | 6.3.3 Austria Gastrointestinal Diseases Market Revenues & Volume, By Irritable Bowel Syndrome, 2021-2031F |
6.3.4 Austria Gastrointestinal Diseases Market Revenues & Volume, By Crohn Disease, 2021-2031F |
6.3.5 Austria Gastrointestinal Diseases Market Revenues & Volume, By Celiac Disease, 2021-2031F |
6.3.6 Austria Gastrointestinal Diseases Market Revenues & Volume, By Gastroenteritis, 2021-2031F |
6.3.7 Austria Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
7 Austria Gastrointestinal Diseases Market Import-Export Trade Statistics |
7.1 Austria Gastrointestinal Diseases Market Export to Major Countries |
7.2 Austria Gastrointestinal Diseases Market Imports from Major Countries |
8 Austria Gastrointestinal Diseases Market Key Performance Indicators |
8.1 Number of gastroenterology clinics and specialized healthcare facilities in Austria |
8.2 Rate of adoption of advanced diagnostic technologies for gastrointestinal diseases |
8.3 Patient satisfaction and outcomes following treatment for gastrointestinal disorders |
9 Austria Gastrointestinal Diseases Market - Opportunity Assessment |
9.1 Austria Gastrointestinal Diseases Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Austria Gastrointestinal Diseases Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Austria Gastrointestinal Diseases Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Austria Gastrointestinal Diseases Market - Competitive Landscape |
10.1 Austria Gastrointestinal Diseases Market Revenue Share, By Companies, 2024 |
10.2 Austria Gastrointestinal Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here